Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Muhammad Wasif Saif

Showing results (331-340 of 473) with videos related to

Pageof 48
Sort By:
Cancer Chemotherapy and Pharmacology|July 1, 2017
Does "OPTINAB" strategy ("stop-and-go") work in treatment of advanced pancreatic cancer (APC) with nab-paclitaxel-gemcitabine?Valerie Relias, Antonia Maloney, Melissa H Smith, et al.
JOP : Journal of the Pancreas|January 14, 2014
Gemcitabine as salvage treatment in patients with poorly differentiated pancreatic neuroendocrine tumors: a case seriesMuhammad Wasif Saif, Kristin Kaley, Teresa Rodriguez, et al.
Journal of Clinical Haematology|April 9, 2021
Lower 24-Month Relative Survival among Black Patients with Non- Hodgkin's Lymphoma: An Analysis of the SEER Data 1997-2015Maria J Nieto, Zhen Li, Hasan Rehman, et al.
JOP : Journal of the Pancreas|July 31, 2014
Chemotherapy and metformin in pancreatic adenocarcinoma and neuroendocrine tumorsSaira Burney, Khadija Irfan Khawaja, Muhammad Wasif Saif, et al.
Journal of Gastrointestinal Oncology|March 5, 2016
Chemotherapy for intraperitoneal use: a review of hyperthermic intraperitoneal chemotherapy and early post-operative intraperitoneal chemotherapyMartin D Goodman, Sarah McPartland, Danielle Detelich, et al.
Cancer Medicine Journal|July 21, 2020
Myelodysplastic Syndrome in Patients with Gastro-Pancreatic Malignancies: A Case Series and Review of LiteratureAmandeep Godara, Anupama Kumar, Kenneth B Miller, et al.
Expert Opinion on Drug Safety|August 12, 2009
Prognostication of pancreatic adenocarcinoma by expression of thymidine phosphorylase/dihydropyrimidine dehydrogenase ratio and its correlation with survivalMuhammad Wasif Saif, Sharukh Hashmi, Diana Bell, et al.
JOP : Journal of the Pancreas|July 13, 2013
New developments in the management of borderline resectable pancreatic cancersMartin David Goodman, Sarah McPartland, Kathryn Huber, et al.
JOP : Journal of the Pancreas|March 13, 2012
Locally advanced pancreatic adenocarcinoma: update and progressJohn Ng, Chi Zhang, Daniela Gidea-Addeo, et al.
JOP : Journal of the Pancreas|March 12, 2013
New developments in the management of borderline resectable pancreatic cancerJaya Sharma, John Ng, Martin D Goodman, et al.
Pageof 48

Showing results (331-340 of 473) with videos related to

Sort By:
Pageof 48
Cancer Chemotherapy and Pharmacology|July 1, 2017
Does "OPTINAB" strategy ("stop-and-go") work in treatment of advanced pancreatic cancer (APC) with nab-paclitaxel-gemcitabine?Valerie Relias, Antonia Maloney, Melissa H Smith, et al.
JOP : Journal of the Pancreas|January 14, 2014
Gemcitabine as salvage treatment in patients with poorly differentiated pancreatic neuroendocrine tumors: a case seriesMuhammad Wasif Saif, Kristin Kaley, Teresa Rodriguez, et al.
Journal of Clinical Haematology|April 9, 2021
Lower 24-Month Relative Survival among Black Patients with Non- Hodgkin's Lymphoma: An Analysis of the SEER Data 1997-2015Maria J Nieto, Zhen Li, Hasan Rehman, et al.
JOP : Journal of the Pancreas|July 31, 2014
Chemotherapy and metformin in pancreatic adenocarcinoma and neuroendocrine tumorsSaira Burney, Khadija Irfan Khawaja, Muhammad Wasif Saif, et al.
Journal of Gastrointestinal Oncology|March 5, 2016
Chemotherapy for intraperitoneal use: a review of hyperthermic intraperitoneal chemotherapy and early post-operative intraperitoneal chemotherapyMartin D Goodman, Sarah McPartland, Danielle Detelich, et al.
Cancer Medicine Journal|July 21, 2020
Myelodysplastic Syndrome in Patients with Gastro-Pancreatic Malignancies: A Case Series and Review of LiteratureAmandeep Godara, Anupama Kumar, Kenneth B Miller, et al.
Expert Opinion on Drug Safety|August 12, 2009
Prognostication of pancreatic adenocarcinoma by expression of thymidine phosphorylase/dihydropyrimidine dehydrogenase ratio and its correlation with survivalMuhammad Wasif Saif, Sharukh Hashmi, Diana Bell, et al.
JOP : Journal of the Pancreas|July 13, 2013
New developments in the management of borderline resectable pancreatic cancersMartin David Goodman, Sarah McPartland, Kathryn Huber, et al.
JOP : Journal of the Pancreas|March 13, 2012
Locally advanced pancreatic adenocarcinoma: update and progressJohn Ng, Chi Zhang, Daniela Gidea-Addeo, et al.
JOP : Journal of the Pancreas|March 12, 2013
New developments in the management of borderline resectable pancreatic cancerJaya Sharma, John Ng, Martin D Goodman, et al.
Pageof 48